Parker Bioscience Filtration is set for expansion following a multimillion-dollar investment from its owners.
The company, part of the global Parker Hannifin group, is set to receive the boost for its Birtley base, to help it increase production capacity. The investment comes as the firm sees growing demand from the pharmaceutical, biopharmaceutical, and food and beverage industries and comes two years after the business expanded its manufacturing facilities to supporting the production of vaccines.
The latest investment includes enhancement of the site’s filter capsule and filter cartridge manufacturing facilities, and installation of a new water treatment plant this year to more than double the site’s water plant capacity. Parker Bioscience Filtration also has sites in Oxnard, US, and Jangangongdan, South Korea, which support customers both locally and globally in improving process control, efficiency and supply chain security.
